| 
			  
			  
			
			
  by Neev M. Arnell
 June 14, 
			2011
 
			from
			
			NaturalNews Website 
			A new book by leading cancer expert, Dr. Samuel S. Epstein, skewers 
			the 
			
			National Cancer Institute and 
			
			American Cancer Society and blames 
			the organizations for America losing the war against cancer.
 
 In the book, "National Cancer Institute and American Cancer Society: 
			Criminal Indifference to Cancer Prevention and Conflicts of 
			Interest," Epstein argues that the NCI and ACS have spent tens of 
			billions of taxpayer and charity dollars focusing on treatment to 
			the exclusion of prevention, which has allowed cancer rates to 
			skyrocket, with the disease now affecting nearly one in two men and 
			more than one in three women.
 
			  
			Furthermore, the author claims that 
			not only do numerous conflicts of interest exist within the NCI and 
			ACS, but the NCI and ACS are also withholding a mass of information 
			on avoidable causes of cancer.
 Epstein, who has served as a consultant for the U.S. Senate 
			Committee on Public Works, is an internationally recognized 
			authority on avoidable causes of cancer, particularly carcinogen 
			exposure through conduits such as food, air, water, household 
			products, cosmetics, prescription drugs or industrial carcinogens in 
			the workplace.
 
 Epstein is professor emeritus of Environmental and Occupational 
			Medicine at the University of Illinois School of Public Health and 
			chairman of the Cancer Prevention Coalition.
 
			  
			He has published more 
			than 270-peer reviewed articles and 20 books, including the 
			prize-winning 1978 The Politics of Cancer, and has appeared on 
			national media, including, 
				
			 
			He was a key expert in the banning of hazardous products 
			including DDT, chlordane and aldrin. 
			  
			In his new book, he is now the 
			leading critic of the cancer establishment for its indifference to 
			prevention of the disease, which, for the ACS, he claims, borders on 
			hostility.
 
			  
			Cancer funding 
			skyrockets along with cancer rates
 
			...followed by exaggerated claims 
			of progress 
			The cancer industry has made a series of misleading claims about the 
			'advances' in the war against cancer over the past three decades, 
			wrote Epstein.
 
 Some of the false claims, according to Epstein, include the 
			industry's 1984 announcement by the NCI that cancer mortality would 
			be halved by 2000, the 1998 NCI and ACS Report Card announcement of 
			a reversal in the almost twenty-year trend of increasing cancer 
			incidence and death, and the 2003 pledge by NCI Director and former 
			ACS president-elect Andrew von Eschenbach to "eliminate suffering 
			and death from cancer by 2015."
 
 The NCI, ACS and the Centers for Disease Control and Prevention also 
			claimed that,
 
				
				"considerable progress has been made in reducing the 
			[number of people with cancer] in the U.S. population" in its 2003 
			"Annual Report to the Nation on the Status of Cancer, 1975-2000." 
			The claim, however, is not consistent with NCI's own data, Epstein 
			said, which shows the overall number of people with cancer and 
			incidence rates actually increased by 18 percent.  
			  
			The data also 
			shows a dramatic increase in nonsmoking-related cancers, according 
			to Epstein, including a 104 percent increase in liver cancer, an 88 
			percent increase in prostate cancer, a 54 percent increase in 
			thyroid and testicular cancer, a 29 percent increase in breast 
			cancer and a 14 percent increase in brain cancer.  
			  
			Epstein also notes 
			the overall cancer mortality rates have remained unchanged and have 
			increase by 6 percent for blacks.
 It seems that the more we spend on cancer, the more cancer we get, 
			Epstein said, because while the number of people with cancer goes 
			up, so does the NCI budget paid for by tax payers and charity.
 
			  
			The 
			NCI budget has increased 25-fold, from $220 million to $4.6 billion, 
			between 1971 and 2000.
 
			  
			Prevention is 
			the key
 
			The fixation on "damage control" instead of prevention is the root 
			cause of the booming cancer rates in the face of billions of dollars 
			aimed at elimination of the disease, according to Epstein.
 
 He claims the NCI priorities are all wrong. The opening statement of 
			the NCI's 2001 Cancer Facts report says that,
 
				
				"cancer prevention is a 
			major component and current priority - to reduce suffering and 
			death from cancer."  
			Meanwhile the report claimed that only 12 
			percent of the NCI's then $3.75 billion budget was allocated to 
			prevention.
 Epstein shows that the actual attention to prevention is probably 
			even less, by citing an analysis of a 1992 NCI budget showing that 
			less than 2.5 percent of its then $2 billion budget was spent on 
			prevention.
 
 Epstein further crucifies NCI stating that prevention tactics 
			defined by NCI only covered the value of avoiding smoking and a bad 
			diet, while wholly ignoring the myriad of environmental and 
			occupational carcinogens.
 
 
			  
			NCI & ACS 
			withholding a mass of cancer prevention information
 
			The NCI has failed to inform the public of published scientific 
			information on a wide range of avoidable causes of multiple cancers, 
			Epstein said.
 
 According to Epstein, there are three major categories of avoidable 
			causes including:
 
				
					
					
					Environmental 
					contaminants in air, water, soil, the workplace, and food
					
					
					
					Carcinogenic 
					ingredients in consumer products, particularly pesticides
					
					Carcinogenic 
					prescription drugs and high-dose diagnostic radiation, 
					particularly pediatric CAT scans 
			Epstein wrote,  
				
				"NCI's silence on 
				cancer prevention is in flagrant violation of the 1971 National 
				Cancer Act's specific charge to disseminate cancer information 
				to the public.  
				  
				This silence is in further violation of the 1988 
				Amendments to the National Cancer Program, which called for an 
				expanded and intensified research program for the prevention of 
				cancer caused by occupational or environmental exposure to 
				carcinogens." 
			Epstein blamed this NCI 
			failure to inform Congress and regulatory agencies of avoidable 
			carcinogens for encouraging petrochemical and other industries to 
			continue manufacturing products containing carcinogens and 
			encouraging corporate polluters to continue polluting.
 NCI's aversion to publicizing avoidable carcinogens has even gone as 
			far as suppression and denial, Epstein said, quoting the following 
			examples:
 
				
				"In 1983, the 
				Department of Health and Human Services directed NCI to 
				investigate the risks of thyroid cancer from I-131 radioactive 
				fallout following atom bomb tests in Nevada in the late 1950s 
				and early 1960s."
 "NCI released its report in 1997, based on data which had been 
				available for over fourteen years, predicting up to 210,000 
				thyroid cancers from radioactive fallout. These cancers, whose 
				incidence has almost doubled since 1973, could have been readily 
				prevented had the NCI warned the public in time and advised them 
				to take thyroid medication."
 
 "At a September 1999 hearing by the Senate Subcommittee of the 
				Committee on Government Affairs, former Senator John Glenn 
				(D-OH) charged that the NCI investigation was plagued by lack of 
				public participation and openness. Senator Tom Harkin (D-IA) 
				charged that NCI's conduct was a travesty."
 
			[Just] as serious is 
			NCI's frank suppression of information.  
			  
			At a 1996 San Francisco Town 
			Hall Meeting on breast cancer, chaired by Congresswoman Nancy Pelosi 
			(D-CA), former NCI director Richard Klausner insisted that, 
				
				"low 
			level diagnostic radiation does not demonstrate an increased risk."
				 
			However, this was contrary to long-term studies on patients with 
			spinal curvature (scoliosis), which showed that such radiation was 
			responsible for 70% excess breast cancer mortality.
 ACS has just as abysmal a track record on prevention as NCI, 
			according to Epstein, and it has been and remains the target of 
			periodic attacks by leading scientists and public interest groups.
 
 One attack in a 1994 press release by the Center for Science in the 
			Public Interest stated,
 
				
				"A group of 24 scientists charged that the 
			ACS was doing little to protect the public from cancer-causing 
			chemicals in the environment and workplace. The scientists urged ACS 
			to revamp its policies and to emphasize prevention in its lobbying 
			and educational campaigns." 
			The scientists criticized ACS for requiring human evidence of 
			carcinogenic effects before implementing regulation, saying that 
			they had an unrealistically high action threshold.  
			  
			The scientists 
			included:  
				
					
					
					Harvard University Nobel Laureates Matthew Meselson and 
			George Wald
					
					former Occupational Safety and Health Director Eula 
			Bingham
					
					past president 
					of the Public Health Association, Anthony Robbins 
			One major instance of ACS ignoring the science, according to 
			Epstein, was in 1993 when they came out in support of the pesticide 
			industry just before the airing of the PBS Frontline special, "In 
			Our Children's Food."  
			  
			ACS released a memorandum in which it 
			trivialized pesticides as a cause of childhood cancers, and 
			reassured the public that pesticide residues were safe, even for 
			infants.
 Possibly most shocking is the failure of the NCI and ACS to inform 
			the public of the increasing incidence of childhood cancers, which 
			has escalated to alarming rates, according to Epstein. The Cancer 
			Prevention Coalition's 2003 report said that childhood cancers have 
			increased by 32 percent between 1975 and 2000 and that cancer is one 
			of the leading causes of death in children, second only to 
			accidents.
 
 Even more shocking, the NCI claims that "the causes of childhood 
			cancer are largely unknown."
 
			  
			This is diametrically opposed to 
			substantial scientific evidence, according to Epstein, which shows 
			that children are exposed to numerous avoidable carcinogens, 
			including everything from X-rays, prescription drugs, pesticides and 
			contaminants in beauty products to petrochemical and industrial 
			pollutants, radioactive pollutants in the air and drinking water, 
			and pollutants from hazardous waste sites.
 In 2000, the industry publication Cancer Letter had a commentary on 
			ACS' behind-the-scenes creation of a legislative committee to gain 
			major control of national cancer policy, according to Epstein.
 
			  
			In the commentary, 
			former executive president of the American Society of Clinical 
			Oncologists Dr. John Durant shared his assessment of ACS behavior. 
				
				"It has always 
				seemed to me that was an issue of control by the ACS over the 
				cancer agenda," Durant said. "They are protecting their own 
				fundraising capacity [from competition by survivor groups.]" 
			
 
			Conflicts of Interest 
			But emphasis on treatment looks likely to remain if, as Epstein 
			shows, the ACS and NCI are in bed with those who profit from a 
			treatment focus.
 
 Approximately half of the members of the ACS board are doctors and 
			scientists with close ties to the NCI, Epstein said. Many of the 
			board members and their colleagues obtain funding from both the ACS 
			and NCI, he said.
 
			  
			Frank conflicts of interest are evident in many 
			ACS priorities, according to Epstein, including the two major 
			examples of mammography and cancer drugs. 
				
				"The ACS has close 
				connections to the mammography industry," Epstein writes.  
				  
				"Five 
				radiologists have served as ACS presidents, and in its every 
				move, the ACS reflects the interests of the major manufacturers 
				of mammogram machines and films... In fact, if every woman 
				followed the ACS and NCI mammography guidelines, the annual 
				revenue to health care facilities would be a staggering $5 
				billion.
 ACS promotion continues to lure women of all ages into 
				mammography centers, leading them to believe that mammography is 
				their best hope against breast cancer. A leading Massachusetts 
				newspaper featured a photograph of two women in their twenties 
				in an ACS advertisement that promised early detection results in 
				a cure "nearly 100 percent of the time."
 
			An ACS communications 
			director responded ....  
				
				"The ad isn't based 
				on a study. When you make an advertisement, you just say what 
				you can to get women in the door. You exaggerate a point. 
				Mammography today is a lucrative [and] highly competitive 
				business."
 "The ACS exposes premenopausal women to radiation hazards from 
				mammography with little or no evidence of benefits," Epstein 
				said.
 
				  
				"The ACS also fails to tell them that their breasts will 
				change so much over time that the 'baseline' images have little 
				or no future relevance." 
			The cancer drug industry 
			is even more lucrative than mammography with annual sales over $12 
			billion.  
			  
			The intimate association between ACS and the pharmaceutical 
			industry is illustrated, Epstein said, by the unbridled aggression 
			which ACS directs at its critics. 
				
				"ACS maintains a 
				Committee on Unproven Methods of Cancer Management, which 
				periodically reviews unorthodox or alternative therapies," 
				Epstein wrote.  
				  
				"This committee is comprised of volunteer health 
				care professionals, carefully selected proponents of orthodox, 
				expensive, and usually toxic drugs patented by major 
				pharmaceutical companies, and opponents of alternative or 
				unproven therapies that are generally cheap, and minimally 
				toxic." 
			Periodically, the 
			committee updates its statements on unproven methods, which are then 
			widely disseminated to clinicians, cheerleader science writers, and 
			the public.  
			  
			Once a clinician or oncologist becomes associated with 
			unproven methods, he or she is blackmailed by the cancer 
			establishment.  
			  
			Funding for the accused quack becomes inaccessible, 
			followed by systematic harassment. 
				
				"The highly biased 
				ACS witch-hunts against alternative practitioners are in 
				striking contrast to its extravagant and uncritical endorsement 
				of conventional toxic chemotherapy.  
				  
				This despite the absence of 
				any objective evidence of improved survival rates or reduced 
				mortality following chemotherapy for all but some relatively 
				rare cancers." 
			The cancer industry's 
			favor of pharmaceutical products is evidenced, Epstein said,  
				
				"by the 
			fact that the U.S. Food and Drug Administration has approved 
			approximately 40 patented drugs for cancer treatment, while it has 
			yet to approve a single non-patented alternative drug." 
			According to Epstein,  
				
				"Dr. Samuel Broder, 
				NCI director from 1989 to 1995, frankly admitted, in a 1998 
				Washington Post interview, that 'the NCI has become what amounts 
				to a government pharmaceutical company.'  
				  
				Taxpayers have funded R 
				& D and expensive clinical trials for over two-thirds of cancer 
				drugs on the market. These drugs are given, with exclusive 
				rights, to the industry, which sells them at inflated prices." 
			
 
			Epstein calls for 
			change 
			NCI reform is two decades overdue, Epstein wrote, based in part on 
			"The Stop Cancer Before it Starts Campaign: How to win the Losing 
			War against Cancer," which is a 2003 report sponsored by eight 
			leading cancer prevention experts and endorsed by over one hundred 
			activists and citizen groups.
 
 Numerous NCI reforms were proposed in 1992 at a Cancer Prevention 
			Coalition press conference, a group of 68 leading cancer prevention 
			and public health experts, past directors of federal agencies, and 
			citizen activists across the nation.
 
			  
			But prophetically, the press 
			release concluded,  
				
				"There is no likelihood that such reforms will be 
			implemented without legislative action." 
			And the ACS has done no better, according to Epstein. 
				
				"The verdict is 
				unassailable," Epstein said.    
				"The ACS bears a major decades-long 
				responsibility for losing the winnable war against cancer. 
				Reforming the ACS is, in principle, relatively easy and directly 
				achievable. Boycott the ACS. Instead, give your charitable 
				contributions to public interest and environmental groups 
				involved in cancer prevention. Such a boycott is well overdue 
				and will send the only message this charity can no longer 
				ignore." |